Badrul A. Chowdhury - 14 Dec 2021 Form 4 Insider Report for Savara Inc (SVRA)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: SVRA
Reported as of: 14 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Dec 2021, 17:26:38 UTC
Prior SEC filing: 09 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ David Lowrance as attorney-in-fact for Badrul Chowdhury

Key filing fact

Badrul A. Chowdhury filed Form 4 for Savara Inc (SVRA) on 14 Dec 2021.

Key facts

This page summarizes Badrul A. Chowdhury's Form 4 filing for Savara Inc (SVRA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Dec 2021, 17:26.

Change

Previous filing in this sequence was filed on 09 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVRA transaction

Common Stock

Award

Transaction value: $0
Shares: +125,000
Change %: +71%
Price: $0.000000
Shares after: 300,000
Date: 14 Dec 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SVRA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 14 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $1.11
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") that vest in full on December 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer.